A Point Mutation in the Groove of HLA-DO Allows Egress from the Endoplasmic Reticulum Independent of HLA-DM

B lymphocytes express the nonclassical class II molecule HLA-DO, which modulates the peptide loading activity of HLA-DM in the endocytic pathway. Binding to HLA-DM is required for HLA-DO to egress from the endoplasmic reticulum (ER). To gain insights into the mode of action of DO and on the role of...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 102; no. 18; pp. 6443 - 6448
Main Authors Deshaies, Francis, Brunet, Alexandre, Diallo, Djibril A., Denzin, Lisa K., Samaan, Angela, Thibodeau, Jacques, Cresswell, Peter
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 03.05.2005
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:B lymphocytes express the nonclassical class II molecule HLA-DO, which modulates the peptide loading activity of HLA-DM in the endocytic pathway. Binding to HLA-DM is required for HLA-DO to egress from the endoplasmic reticulum (ER). To gain insights into the mode of action of DO and on the role of DM in ER release, we sought to identify DM-binding residues on DO. Our results show that DOα encompasses the binding site for HLA-DM. More specifically, mutation of residue DOα41 on an exposed lateral loop of the α1 domain affects the binding to DM, ER egress, and activity of DO. Using a series of chimeric DR/DO molecules, we confirmed the role of the α chain and established that a second DM-binding region is located C-terminal to the DOα80 residue, most probably in the α2 domain. Interestingly, after mutation of a buried proline (α11) on the floor of the putative peptide-binding groove, HLA-DO remained functional but became independent of HLA-DM for ER egress and intracellular trafficking. Collectively, these results suggest that the binding of HLA-DM to DOα allows the complex to egress from the ER by stabilizing intramolecular contacts between the N-terminal antiparallel β-strands of the DOαβ heterodimer.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
To whom correspondence may be addressed. E-mail: jacques.thibodeau@umontreal.ca or asamaan@pasteur.fr.
Author contributions: F.D., A.B., A.S., and J.T. designed research; F.D., A.B., and D.A.D. performed research; L.K.D. and A.S. contributed new reagents/analytic tools; F.D., A.B., D.A.D., L.K.D., and J.T. analyzed data; and F.D., A.B., L.K.D., A.S., and J.T. wrote the paper.
Abbreviations: ER, endoplasmic reticulum; Ii, invariant chain; CLIP, class II-associated Ii peptide; CIITA, class II transactivator; cDO, chimeric DO.
This paper was submitted directly (Track II) to the PNAS office.
Edited by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved March 17, 2005
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0500853102